Today: 26 June 2026
Browse Category

Stock Market 27 January 2026

Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana shares fell about 12% in premarket trading Tuesday after a U.S. proposal signaled minimal Medicare Advantage payment growth for 2027. The Centers for Medicare & Medicaid Services set a net average increase of 0.09%, citing risk score changes and new limits on chart review diagnoses. UnitedHealth and CVS Health also dropped around 9%. Investors await the April 6 final rate notice.
27 January 2026
CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS Health shares fell about 9% in premarket trading after CMS announced a 0.09% net average payment increase for 2027 Medicare Advantage plans, far below investor expectations. The agency set a Feb. 25 deadline for comments and will finalize rates by April 6. UnitedHealth and Humana also dropped in after-hours trading. Insurers face pressure as Medicare Advantage remains a key profit source.
27 January 2026
Micron stock jumps in premarket on $24B Singapore fab plan as AI memory crunch tightens

Micron stock jumps in premarket on $24B Singapore fab plan as AI memory crunch tightens

Micron shares rose about 4% in premarket trading Tuesday after the company announced a $24 billion expansion of its Singapore manufacturing site, with wafer production set for late 2028. The move comes as memory chip supply remains tight and analysts expect enterprise SSD prices to jump up to 60%. Executive vice president Manish Bhatia sold over 26,000 shares last week, regulatory filings show.
CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open

CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open

CoreWeave shares rose 5.7% to $98.31 premarket Monday after Nvidia announced a $2 billion investment at $87.20 per share, becoming the company’s second-largest shareholder. The private sale adds nearly 23 million shares to Nvidia’s stake. CoreWeave said it will use the funds to expand data centers and research, not to buy Nvidia processors. Investors are watching if CRWV holds above Nvidia’s purchase price ahead of a busy tech earnings week.
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
SSE PLC share price ticks up in London as Jan 30 dividend nears — what to watch next

SSE PLC share price ticks up in London as Jan 30 dividend nears — what to watch next

SSE shares edged up 0.1% to 2,358 pence in early London trading Tuesday, after a 1.5% gain Monday. Volume remained thin, with about 308,000 shares traded versus a three-month average of 3.6 million. Investors await an interim dividend payment and scrip share admission on Jan. 30, followed by a Q3 trading update on Feb. 4. UK 10-year gilt yields rose to 4.509%, keeping utilities in focus.
27 January 2026
Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock shares slipped 0.34% to 1,449p in early London trading after announcing further share buybacks. Jefferies and JPMorgan raised their target prices to 1,670p and 1,700p, respectively, as investors watch for a June board handover. The company reaffirmed its FY26 outlook and margin target, citing contracted revenue and new Arrowhead licence deals in Indonesia.
27 January 2026
Vodafone share price slips as Centrica partnership lands — and buyback rolls on

Vodafone share price slips as Centrica partnership lands — and buyback rolls on

Vodafone shares fell 0.3% to 104.2 pence in early London trading, retreating from Monday’s 52-week high. The company signed a four-year workplace and connectivity contract with Centrica, covering 80 UK sites and 30,000 devices. Vodafone also repurchased 2.57 million shares on Jan. 26 at an average 104.82 pence each. Financial terms of the Centrica deal were not disclosed.
27 January 2026
Fresnillo PLC share price slips in London after gold’s $5,000 surge — what investors watch next

Fresnillo PLC share price slips in London after gold’s $5,000 surge — what investors watch next

Fresnillo shares fell 3.2% to 4,304 pence in early London trading Tuesday, retreating from Monday’s 6.7% surge and recent highs. The drop comes ahead of the company’s quarterly production report due Wednesday, with gold and silver prices hovering near records on safe-haven demand. Fresnillo recently completed a C$770 million acquisition of Probe Gold.
27 January 2026

Stock Market Today

  • SQQQ ETF Not Recommended for Long-Term Tech Shorting
    June 26, 2026, 4:20 PM EDT. ProShares UltraPro Short QQQ (SQQQ) ETF is rated a Sell because it is unsuitable as a long-term hedge or investment tool. The fund aims to deliver three times the inverse daily performance of the Nasdaq-100 index, making it a tactical rather than strategic option. Investors seeking consistent short exposure to technology stocks should consider the ETF's potential for value erosion over time due to daily reset mechanics. The SQQQ is best used for short-term market timing rather than prolonged market bets.

Latest News

AT&T dividend yield near 5% puts cash flow back in the spotlight

AT&T dividend yield near 5% puts cash flow back in the spotlight

26 June 2026
AT&T (NYSE:T) rose 0.6% to $22.55 as investors weighed its 4.9% dividend yield and $8 billion 2026 buyback—together nearly 10% of equity value—against Q2 free-cash-flow guidance of $4.0–$4.5 billion, which would cover the dividend by just over 2x ahead of July 22 results.
Go toTop